Medpace Holdings, Inc.
Simbolis: MEDP
NASDAQ
392.57
USDRinkos kaina šiandien
38.7448
P/E santykis
0.0000
PEG koeficientas
12.16B
MRK kapitalizacija
- 0.00%
DIV pajamingumas
Medpace Holdings, Inc. (MEDP) Finansinės ataskaitos
Balansas
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 786.8 | 245.4 | 28.3 | 461.3 | ||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.net-receivables | 1145.4 | 298.4 | 253.4 | 186.4 | ||||||||||
balance-sheet.row.inventory | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.other-current-assets | 234.34 | 50 | 52.3 | 43.2 | ||||||||||
balance-sheet.row.total-current-assets | 2166.54 | 593.8 | 334 | 690.9 | ||||||||||
balance-sheet.row.property-plant-equipment-net | 1036.38 | 265.4 | 248.9 | 222.7 | ||||||||||
balance-sheet.row.goodwill | 2649.58 | 662.4 | 662.4 | 662.4 | ||||||||||
balance-sheet.row.intangible-assets | 144.52 | 35.8 | 38 | 41.4 | ||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 2794.11 | 698.2 | 700.4 | 703.8 | ||||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.tax-assets | 260.77 | 74.4 | 48.1 | 25.1 | ||||||||||
balance-sheet.row.other-non-current-assets | 88.47 | 25 | 21.1 | 17.4 | ||||||||||
balance-sheet.row.total-non-current-assets | 4179.74 | 1063 | 1018.5 | 969 | ||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-assets | 6346.28 | 1656.8 | 1352.5 | 1659.9 | ||||||||||
balance-sheet.row.account-payables | 118.9 | 31.9 | 33.1 | 25.7 | ||||||||||
balance-sheet.row.short-term-debt | 885.06 | 293 | 50 | 159.3 | ||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.long-term-debt-total | 560.71 | 142.1 | 138.9 | 131 | ||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 6.99 | - | - | - | ||||||||||
balance-sheet.row.other-current-liab | 392.9 | 40.4 | 257.7 | 27.6 | ||||||||||
balance-sheet.row.total-non-current-liabilities | 671.08 | 172.7 | 162.6 | 149.8 | ||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.capital-lease-obligations | 560.71 | 142.1 | 138.9 | 131 | ||||||||||
balance-sheet.row.total-liab | 4253.81 | 1097.9 | 966.1 | 707 | ||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.common-stock | 1.23 | 0.3 | 0.3 | 0.4 | ||||||||||
balance-sheet.row.retained-earnings | -1012 | -221.6 | -359.8 | 235 | ||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -46.18 | -10.1 | -12.4 | -4.8 | ||||||||||
balance-sheet.row.other-total-stockholders-equity | 3149.41 | 790.4 | 758.3 | 722.4 | ||||||||||
balance-sheet.row.total-stockholders-equity | 2092.46 | 559 | 386.4 | 952.9 | ||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 6346.28 | 1656.8 | 1352.5 | 1659.9 | ||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-equity | 2092.46 | 559 | 386.4 | 952.9 | ||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 6346.28 | - | - | - | ||||||||||
Total Investments | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-debt | 615.71 | 142.1 | 188.9 | 131 | ||||||||||
balance-sheet.row.net-debt | -171.1 | -103.3 | 160.6 | -330.3 |
Pinigų srautų ataskaita
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 312.51 | 282.8 | 245.4 | 181.8 | ||||||||||
cash-flows.row.depreciation-and-amortization | 27.36 | 26.3 | 22.3 | 21.1 | ||||||||||
cash-flows.row.deferred-income-tax | -24.92 | -25.1 | -23 | -37.1 | ||||||||||
cash-flows.row.stock-based-compensation | 19.39 | 20.5 | 21.4 | 14.5 | ||||||||||
cash-flows.row.change-in-working-capital | 151.12 | 106.5 | 106.1 | 66.7 | ||||||||||
cash-flows.row.account-receivables | -24.82 | -48.3 | -66.9 | -25 | ||||||||||
cash-flows.row.inventory | 43.94 | 66.2 | 0 | 25 | ||||||||||
cash-flows.row.account-payables | -10.76 | 1.1 | 6.4 | 1.9 | ||||||||||
cash-flows.row.other-working-capital | 179.05 | 87.5 | 166.5 | 64.8 | ||||||||||
cash-flows.row.other-non-cash-items | 20.52 | 22.4 | 15.9 | 16.3 | ||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 505.98 | 0 | 0 | 0 | ||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -32.63 | -36.6 | -36.9 | -28.3 | ||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.other-investing-activites | 10.04 | 2 | -1.9 | -3.1 | ||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -22.6 | -34.6 | -38.7 | -31.4 | ||||||||||
cash-flows.row.debt-repayment | -130 | -155 | -274.2 | 0 | ||||||||||
cash-flows.row.common-stock-issued | 16.57 | 11.4 | 22.1 | 17.6 | ||||||||||
cash-flows.row.common-stock-repurchased | -23.87 | -144 | -847.8 | -62.1 | ||||||||||
cash-flows.row.dividends-paid | 0 | -11.4 | -22.1 | 0 | ||||||||||
cash-flows.row.other-financing-activites | -23.43 | 116.4 | 346.3 | -44.5 | ||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -122.3 | -182.6 | -775.8 | -44.5 | ||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -0.99 | 1.1 | -6.6 | -4 | ||||||||||
cash-flows.row.net-change-in-cash | 360.09 | 217.2 | -433 | 183.5 | ||||||||||
cash-flows.row.cash-at-end-of-period | 786.8 | 245.4 | 28.3 | 461.3 | ||||||||||
cash-flows.row.cash-at-beginning-of-period | 426.72 | 28.3 | 461.3 | 277.8 | ||||||||||
cash-flows.row.operating-cash-flow | 505.98 | 433.4 | 388.1 | 263.3 | ||||||||||
cash-flows.row.capital-expenditure | -32.63 | -36.6 | -36.9 | -28.3 | ||||||||||
cash-flows.row.free-cash-flow | 473.34 | 396.7 | 351.2 | 235.1 |
Pajamų ataskaitos eilutė
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1962.81 | 1885.8 | 1460 | 1142.4 | ||||||||||
income-statement-row.row.cost-of-revenue | 1413.35 | 1361.3 | 1027.6 | 814.2 | ||||||||||
income-statement-row.row.gross-profit | 549.46 | 524.5 | 432.4 | 328.2 | ||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||
income-statement-row.row.selling-general-administrative | 41.01 | - | - | - | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 1.5 | - | - | - | ||||||||||
income-statement-row.row.other-expenses | 12.98 | 1.3 | 22.3 | 21.1 | ||||||||||
income-statement-row.row.operating-expenses | 194.77 | 187.7 | 153.7 | 129.5 | ||||||||||
income-statement-row.row.cost-and-expenses | 1608.12 | 1549 | 1181.3 | 943.8 | ||||||||||
income-statement-row.row.interest-income | 3.31 | 0 | 2.9 | 0.1 | ||||||||||
income-statement-row.row.interest-expense | 7.43 | -0.5 | 2.9 | -0.1 | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 1.5 | - | - | - | ||||||||||
income-statement-row.row.total-other-income-expensenet | 1.89 | -0.7 | 4.2 | 3.2 | ||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||
income-statement-row.row.other-operating-expenses | 12.98 | 1.3 | 22.3 | 21.1 | ||||||||||
income-statement-row.row.total-operating-expenses | 1.89 | -0.7 | 4.2 | 3.2 | ||||||||||
income-statement-row.row.interest-expense | 7.43 | -0.5 | 2.9 | -0.1 | ||||||||||
income-statement-row.row.depreciation-and-amortization | 26.08 | 26.3 | 22.3 | 21.1 | ||||||||||
income-statement-row.row.ebitda-caps | 381.37 | - | - | - | ||||||||||
income-statement-row.row.operating-income | 354.69 | 336.8 | 278.7 | 198.6 | ||||||||||
income-statement-row.row.income-before-tax | 362.43 | 335.7 | 282.9 | 201.9 | ||||||||||
income-statement-row.row.income-tax-expense | 49.93 | 52.9 | 37.5 | 20 | ||||||||||
income-statement-row.row.net-income | 312.51 | 282.8 | 245.4 | 181.8 |
Dažnai užduodami klausimai
Kas yra Medpace Holdings, Inc. (MEDP) bendras turtas?
Medpace Holdings, Inc. (MEDP) bendras turtas yra 1656828000.000.
Kokios yra įmonės metinės pajamos?
Metinės pajamos yra 1009445000.000.
Kokia yra įmonės pelno marža?
Įmonės pelno marža yra 0.280.
Koks yra įmonės laisvųjų pinigų srautas?
Laisvųjų pinigų srautas yra 15.347.
Kokia yra įmonės grynojo pelno marža?
Grynojo pelno marža yra 0.159.
Kokios yra bendros įmonės pajamos?
Bendrosios pajamos yra 0.181.
Kas yra Medpace Holdings, Inc. (MEDP) grynasis pelnas (grynosios pajamos)?
Grynasis pelnas (grynosios pajamos) yra 282810000.000.
Kokia yra bendra įmonės skola?
Bendra skola yra 142122000.000.
Koks yra veiklos sąnaudų skaičius?
Veiklos sąnaudos yra 187680000.000.
Koks yra įmonės grynųjų pinigų skaičius?
Įmonės grynieji pinigai yra 407010000.000.